Form 8-K - Current report:
SEC Accession No. 0001558370-21-000546
Filing Date
2021-01-29
Accepted
2021-01-29 16:30:24
Documents
2
Period of Report
2020-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20201130x8k.htm 8-K 38445
2 EX-10.1 tmb-20201130xex10d1.htm EX-10.1 300995
  Complete submission text file 0001558370-21-000546.txt   340670
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 21571603
SIC: 2836 Biological Products, (No Diagnostic Substances)